Trump’s return poses uncertainty for U.S. pharma and healthcare industries
New Delhi: Donald Trump’s return to the White House has created uncertainty over the U.S. pharmaceutical and healthcare sectors. As Trump most likely to implement major policy changes that could affect millions. According to data and analytics firm …